UR
GILD icon

USCA RIA’s Gilead Sciences GILD Stock Holding History

USCA RIA’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$5.63M Sell
81,816
-676
-0.8% -$45.1K 0.34% 81
2021
Q1 		$5.33M Buy
82,492
+8,644
+12% +$557K 0.35% 83
2020
Q4 		$4.3M Sell
73,848
-20,975
-22% -$1.27M 0.3% 74
2020
Q3 		$5.99M Sell
94,823
-50,916
-35% -$3.53M 0.47% 48
2020
Q2 		$11.2M Sell
145,739
-2,714
-2% -$208K 0.99% 16
2020
Q1 		$11.1M Buy
148,453
+5,870
+4% +$406K 1.29% 10
2019
Q4 		$9.27M Sell
142,583
-8,703
-6% -$567K 0.83% 21
2019
Q3 		$9.59M Sell
151,286
-4,606
-3% -$301K 0.94% 18
2019
Q2 		$10.5M Buy
155,892
+6,030
+4% +$397K 1.07% 12
2019
Q1 		$9.74M Buy
149,862
+56,003
+60% +$3.72M 1.06% 12
2018
Q4 		$5.87M Sell
93,859
-5,543
-6% -$387K 0.78% 33
2018
Q3 		$7.67M Sell
99,402
-38,915
-28% -$2.94M 0.78% 31
2018
Q2 		$9.8M Buy
138,317
+47,143
+52% +$3.33M 1.05% 13
2018
Q1 		$6.87M Sell
91,174
-643
-0.7% -$51.1K 0.76% 29
2017
Q4 		$6.58M Buy
91,817
+17,591
+24% +$1.34M 0.73% 32
2017
Q3 		$5.25M Hold
74,226
– – 0.68% 36
2017
Q2 		$5.25M Buy
74,226
+16,693
+29% +$1.11M 0.67% 37
2017
Q1 		$3.91M Buy
57,533
+38,565
+203% +$2.71M 0.57% 43
2016
Q4 		$1.36M Sell
18,968
-8,047
-30% -$598K 0.21% 143
2016
Q3 		$2.14M Sell
27,015
-106
-0.4% -$8.61K 0.35% 78
2016
Q2 		$2.26M Buy
27,121
+677
+3% +$60.1K 0.38% 71
2016
Q1 		$2.43M Buy
26,444
+17,869
+208% +$1.61M 0.44% 63
2015
Q4 		$868K Buy
8,575
+1,528
+22% +$159K 0.19% 154
2015
Q3 		$692K Sell
7,047
-3,851
-35% -$428K 0.17% 157
2015
Q2 		$1.28M Buy
10,898
+1,129
+12% +$123K 0.34% 83
2015
Q1 		$959K Buy
9,769
+4,728
+94% +$480K 0.26% 118
2014
Q4 		$475K Buy
5,041
+2,950
+141% +$305K 0.13% 181
2014
Q3 		$223K Buy
+2,091
New +$205K 0.07% 282
2014
Q2 		– Sell
-3,207
Closed -$227K – 296
2014
Q1 		$227K Buy
+3,207
New +$252K 0.08% 241

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

USCA RIA's GILD Position: Q2 2021 in Review

USCA RIA reduced its Gilead Sciences (GILD) stake by 0.82% in Q2 2021, selling an estimated $45.1K and leaving 81,816 shares worth $5.63M. The position accounts for 0.34% of the portfolio, ranked #81.

USCA RIA first reported a position in GILD in Q1 2014 and has held it in 29 quarters since. The position peaked at $11.2M in Q2 2020. 1,544 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

  • USCA RIA held 81,816 shares of Gilead Sciences worth $5.63M as of Q2 2021.
  • USCA RIA sold 676 Gilead Sciences shares in Q2 2021, an estimated $45.1K.
  • Gilead Sciences made up 0.34% of USCA RIA's portfolio in Q2 2021, its #81 holding.
  • USCA RIA first reported a position in Gilead Sciences in Q1 2014 and has held it in 29 quarters since.
  • USCA RIA's Gilead Sciences position peaked at $11.2M in Q2 2020.
  • 1,544 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.